ClinicalTrials.gov
public full text
Public Domain
Origin of CEC in Patients After Allo-HSCT
We believe that CEC, besides coming from cells shedding from patient vasculature, could partly belong to donor, originating from the cellular graft.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Expanded Use of G-CSF Mobilized Donor CD34+ Selected Cells for Allogeneic Transplantation#829470
- Targeted proteomics reveal histiocytosis-associated neurodegeneration signatures#784516
- Study of the Correlation Between Donor CIRBP and Transplanted Kidney Function#873129
- Minimização da agregação proteica de fragmentos de anticorpos de cadeia única (scFv) com aplicação em terapias de células CAR-T#977074
- Clinical Study of ALLO-ASC-SHEET in Subjects with Diabetic Foot Ulcers#377355
Record · ID 857050
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive